New patent expiration for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF

Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF Flonase Sensimist Allergy Relief is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from one supplier. There…

The post New patent expiration for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF appeared first on DrugPatentWatch - Make Better Decisions.

Biotechblog
Scroll to Top